Maria L. Martin
Salamanca, CL 37007, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Corrigendum to "Chronic sarpogrelate treatment improves renal sympathetic hyperactivity in experimental diabetes"[Biomed. Pharmacother. 176 (2024) 116814].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 13, 2026
Cost Analysis of Multidose Drug Dispensing (MDD) System Implementation in a Community Pharmacy in Portugal.
Journal: Pharmacy (Basel, Switzerland)
Published: September 09, 2025
Sex influence on serotonergic modulation of the vascular noradrenergic drive in rats.
Journal: British journal of pharmacology
Published: April 30, 2024
Chronic sarpogrelate treatment improves renal sympathetic hyperactivity in experimental diabetes.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 06, 2024
Renal Sympathetic Hyperactivity in Diabetes Is Modulated by 5-HT1D Receptor Activation via NO Pathway.
Journal: International journal of molecular sciences
Published: November 28, 2022
Fluoxetine Treatment Decreases Cardiac Vagal Input and Alters the Serotonergic Modulation of the Parasympathetic Outflow in Diabetic Rats.
Journal: International journal of molecular sciences
Published: April 28, 2022
Effect of sarpogrelate treatment on 5-HT modulation of vascular sympathetic innervation and platelet activity in diabetic rats.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 19, 2022
Oral fluoxetine treatment changes serotonergic sympatho-regulation in experimental type 1 diabetes.
Journal: Life sciences
Published: December 21, 2021
Vascular sympathetic neurotransmission and its serotonergic regulation are modified by chronic fluoxetine treatment.
Journal: Journal of pharmacological sciences
Published: April 08, 2021
Dopamine D4 receptor subtype activation reduces the rat cardiac parasympathetic discharge.
Journal: Pflugers Archiv : European journal of physiology
Published: July 03, 2020
Fluoxetine oral treatment discloses 5-HT1D receptor as vagoinhibitor of the cardiac cholinergic neurotransmission in rat.
Journal: Canadian journal of physiology and pharmacology
Published: November 22, 2018
Hypertension exhibits 5-HT4 receptor as a modulator of sympathetic neurotransmission in the rat mesenteric vasculature.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: August 02, 2018
Last Updated: 09/26/2026